Olanzapine updated on 06-10-2025

Neonatal disorders (as a whole)

R analysis
id Study   Lib. in paper Exposition period    Study type 
 Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S2450
R3105		 Habermann (Control exposed to FGA), 2013 Postnatal disorders late pregnancy prospective cohort exposed to other treatment, sick excluded Adjustment: No 0.65 [0.30;1.38] C
excluded (control group) 		13/86   22/102 35 86
ref
S2449
R3104		 Habermann (Unexposed control), 2013 Postnatal disorders late pregnancy prospective cohort unexposed, disease free Adjustment: No 4.02 [2.07;7.81] C 13/86   43/1,014 56 86
ref
Total 1 studies 4.02 [2.07;7.81] 56 86
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Habermann (Unexposed control), 2013Habermann, 2013 1 4.02[2.07; 7.81]56860%ROB confusion: criticalROB selection: moderateROB classification: moderateROB missing: moderateROB mesure: moderateROB reporting: moderate0.910.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Unexposed control;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 4.02[2.07; 7.81]5686 -NAHabermann (Unexposed control), 2013 1 case control studiescase control studies 0 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 4.02[2.07; 7.81]5686 -NAHabermann (Unexposed control), 2013 1 Tags Adjustment   - No  - No 4.02[2.07; 7.81]5686 -NAHabermann (Unexposed control), 2013 1 All studiesAll studies 4.02[2.07; 7.81]5686 -NAHabermann (Unexposed control), 2013 10.510.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 2450

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 4.02[2.07; 7.81]5686 -NAHabermann (Unexposed control), 2013 1 exposed to other treatment, sick controlsexposed to other treatment, sick controls 0.65[0.30; 1.38]3586 -NAHabermann (Control exposed to FGA), 2013 10.510.01.0